The Medicines Company Reports Third-Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St set for lower open as bond yields climb; Walmart falls
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Medicines Co. (MDCO) Posts Narrower-than-Expected Q3 Loss
October 26, 2016 7:02 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($0.64), $0.66 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $37.6 million versus the consensus estimate of $37.26 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More